STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended
	Feb. 08, 2016 USD ($) shares	Jan. 01, 2016 € / shares shares	Jan. 01, 2016 USD ($) shares	Jan. 02, 2015 USD ($) shares	Nov. 30, 2015 shares	Oct. 02, 2015 shares	[1]	Apr. 30, 2015
Shareholders Equity [Line Items]
Number of shares authorized to be repurchased by VMS Board of Directors					8,000,000
Repurchases of common stock | $			$ 192,077	$ 125,535
Number of shares remain available for repurchase		7,000,000
Common stock, shares outstanding (in shares)		95,999,000				98,070,000
Number of shares			2,425,000	1,500,000
Subsequent Event | January 2016
Shareholders Equity [Line Items]
Repurchases of common stock | $	$ 40,400
Number of shares	519,186
Noncontrolling Interests
Shareholders Equity [Line Items]
Reclassification of noncontrolling interests in MeVis to redeemable noncontrolling interests | $			$ 10,382
MeVis Medical Solutions AG (MeVis)
Shareholders Equity [Line Items]
Annual recurring compensation (in euro per share) | € / shares		€ 0.95
Put right (in euro per share) | € / shares		€ 19.77
Percentage of voting interest acquired								73.50%
MeVis Medical Solutions AG (MeVis) | Noncontrolling Interests
Shareholders Equity [Line Items]
Common stock, shares outstanding (in shares)		482,000
Noncontrolling interest (as a percent)		26.50%

[1] The condensed consolidated balance sheet as of October 2, 2015 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.